Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013125 |
---|---|
Receipt number | R000015308 |
Scientific Title | A efficacy of maintenance intensification therapy by(Bevacizumab)/Pemetrexed/Carboplatin or Cisplatin after induction therapy by Erlotinib for EGFR mutation positive non -spuamous non-small cell lung cancer. |
Date of disclosure of the study information | 2014/02/10 |
Last modified on | 2019/08/21 20:53:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/02/10 19:36:10 | ||
2 | Update | 2014/02/12 09:14:16 | Recruitment status |
|
3 | Update | 2014/02/12 09:14:58 | UMIN ID1 |
|
4 | Update | 2014/06/23 17:21:12 | Recruitment status |
|
5 | Update | 2016/03/17 15:00:24 | Organization1 Email1 |
|
6 | Update | 2019/08/21 20:35:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
7 | Update | 2019/08/21 20:49:14 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
8 | Update | 2019/08/21 20:53:56 | Number of participants that the trial has enrolled |